Global Gene Engineered Subunit Vaccine Market Research Report 2025(Status and Outlook)
Report Overview
A gene engineered subunit vaccine or a bio-recombinant subunit vaccine refers to the expression of a protective antigen gene in a prokaryotic or eukaryotic cell, and a vaccine made from a gene product?protein or polypeptide.
This report provides a deep insight into the global Gene Engineered Subunit Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gene Engineered Subunit Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gene Engineered Subunit Vaccine market in any manner.
Global Gene Engineered Subunit Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
GSK
Tiantan
Pulike
Greffex
CureVac
Yebio
Sanofi Pasteur SA
Virbac
Pfizer Inc.
Walvax Biotechnology
Kontec
Novavax
Sanofi Pasteur
Bharat Biotech
GlaxoSmithKline
Pfizer
Moderna
Market Segmentation (by Type)
Therapeutic Gene Engineered Subunit Vaccine
Preventative Gene Engineered Subunit Vaccine
Market Segmentation (by Application)
Human Use
Veterinary Use
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Gene Engineered Subunit Vaccine Market
Overview of the regional outlook of the Gene Engineered Subunit Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene Engineered Subunit Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gene Engineered Subunit Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
A gene engineered subunit vaccine or a bio-recombinant subunit vaccine refers to the expression of a protective antigen gene in a prokaryotic or eukaryotic cell, and a vaccine made from a gene product?protein or polypeptide.
This report provides a deep insight into the global Gene Engineered Subunit Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gene Engineered Subunit Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gene Engineered Subunit Vaccine market in any manner.
Global Gene Engineered Subunit Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
GSK
Tiantan
Pulike
Greffex
CureVac
Yebio
Sanofi Pasteur SA
Virbac
Pfizer Inc.
Walvax Biotechnology
Kontec
Novavax
Sanofi Pasteur
Bharat Biotech
GlaxoSmithKline
Pfizer
Moderna
Market Segmentation (by Type)
Therapeutic Gene Engineered Subunit Vaccine
Preventative Gene Engineered Subunit Vaccine
Market Segmentation (by Application)
Human Use
Veterinary Use
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Gene Engineered Subunit Vaccine Market
Overview of the regional outlook of the Gene Engineered Subunit Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene Engineered Subunit Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gene Engineered Subunit Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Gene Engineered Subunit Vaccine
1.2 Key Market Segments
1.2.1 Gene Engineered Subunit Vaccine Segment by Type
1.2.2 Gene Engineered Subunit Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENE ENGINEERED SUBUNIT VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gene Engineered Subunit Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Gene Engineered Subunit Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENE ENGINEERED SUBUNIT VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Gene Engineered Subunit Vaccine Product Life Cycle
3.3 Global Gene Engineered Subunit Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Gene Engineered Subunit Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Gene Engineered Subunit Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gene Engineered Subunit Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Gene Engineered Subunit Vaccine Market Competitive Situation and Trends
3.8.1 Gene Engineered Subunit Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gene Engineered Subunit Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GENE ENGINEERED SUBUNIT VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Gene Engineered Subunit Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENE ENGINEERED SUBUNIT VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gene Engineered Subunit Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Gene Engineered Subunit Vaccine Market
5.7 ESG Ratings of Leading Companies
6 GENE ENGINEERED SUBUNIT VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene Engineered Subunit Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Gene Engineered Subunit Vaccine Market Size Market Share by Type (2020-2025)
6.4 Global Gene Engineered Subunit Vaccine Price by Type (2020-2025)
7 GENE ENGINEERED SUBUNIT VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene Engineered Subunit Vaccine Market Sales by Application (2020-2025)
7.3 Global Gene Engineered Subunit Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Gene Engineered Subunit Vaccine Sales Growth Rate by Application (2020-2025)
8 GENE ENGINEERED SUBUNIT VACCINE MARKET SALES BY REGION
8.1 Global Gene Engineered Subunit Vaccine Sales by Region
8.1.1 Global Gene Engineered Subunit Vaccine Sales by Region
8.1.2 Global Gene Engineered Subunit Vaccine Sales Market Share by Region
8.2 Global Gene Engineered Subunit Vaccine Market Size by Region
8.2.1 Global Gene Engineered Subunit Vaccine Market Size by Region
8.2.2 Global Gene Engineered Subunit Vaccine Market Size Market Share by Region
8.3 North America
8.3.1 North America Gene Engineered Subunit Vaccine Sales by Country
8.3.2 North America Gene Engineered Subunit Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gene Engineered Subunit Vaccine Sales by Country
8.4.2 Europe Gene Engineered Subunit Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gene Engineered Subunit Vaccine Sales by Region
8.5.2 Asia Pacific Gene Engineered Subunit Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Gene Engineered Subunit Vaccine Sales by Country
8.6.2 South America Gene Engineered Subunit Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Gene Engineered Subunit Vaccine Sales by Region
8.7.2 Middle East and Africa Gene Engineered Subunit Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GENE ENGINEERED SUBUNIT VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Gene Engineered Subunit Vaccine by Region(2020-2025)
9.2 Global Gene Engineered Subunit Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Gene Engineered Subunit Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gene Engineered Subunit Vaccine Production
9.4.1 North America Gene Engineered Subunit Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Gene Engineered Subunit Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gene Engineered Subunit Vaccine Production
9.5.1 Europe Gene Engineered Subunit Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Gene Engineered Subunit Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gene Engineered Subunit Vaccine Production (2020-2025)
9.6.1 Japan Gene Engineered Subunit Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Gene Engineered Subunit Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gene Engineered Subunit Vaccine Production (2020-2025)
9.7.1 China Gene Engineered Subunit Vaccine Production Growth Rate (2020-2025)
9.7.2 China Gene Engineered Subunit Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Merck
10.1.1 Merck Basic Information
10.1.2 Merck Gene Engineered Subunit Vaccine Product Overview
10.1.3 Merck Gene Engineered Subunit Vaccine Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck SWOT Analysis
10.1.6 Merck Recent Developments
10.2 GSK
10.2.1 GSK Basic Information
10.2.2 GSK Gene Engineered Subunit Vaccine Product Overview
10.2.3 GSK Gene Engineered Subunit Vaccine Product Market Performance
10.2.4 GSK Business Overview
10.2.5 GSK SWOT Analysis
10.2.6 GSK Recent Developments
10.3 Tiantan
10.3.1 Tiantan Basic Information
10.3.2 Tiantan Gene Engineered Subunit Vaccine Product Overview
10.3.3 Tiantan Gene Engineered Subunit Vaccine Product Market Performance
10.3.4 Tiantan Business Overview
10.3.5 Tiantan SWOT Analysis
10.3.6 Tiantan Recent Developments
10.4 Pulike
10.4.1 Pulike Basic Information
10.4.2 Pulike Gene Engineered Subunit Vaccine Product Overview
10.4.3 Pulike Gene Engineered Subunit Vaccine Product Market Performance
10.4.4 Pulike Business Overview
10.4.5 Pulike Recent Developments
10.5 Greffex
10.5.1 Greffex Basic Information
10.5.2 Greffex Gene Engineered Subunit Vaccine Product Overview
10.5.3 Greffex Gene Engineered Subunit Vaccine Product Market Performance
10.5.4 Greffex Business Overview
10.5.5 Greffex Recent Developments
10.6 CureVac
10.6.1 CureVac Basic Information
10.6.2 CureVac Gene Engineered Subunit Vaccine Product Overview
10.6.3 CureVac Gene Engineered Subunit Vaccine Product Market Performance
10.6.4 CureVac Business Overview
10.6.5 CureVac Recent Developments
10.7 Yebio
10.7.1 Yebio Basic Information
10.7.2 Yebio Gene Engineered Subunit Vaccine Product Overview
10.7.3 Yebio Gene Engineered Subunit Vaccine Product Market Performance
10.7.4 Yebio Business Overview
10.7.5 Yebio Recent Developments
10.8 Sanofi Pasteur SA
10.8.1 Sanofi Pasteur SA Basic Information
10.8.2 Sanofi Pasteur SA Gene Engineered Subunit Vaccine Product Overview
10.8.3 Sanofi Pasteur SA Gene Engineered Subunit Vaccine Product Market Performance
10.8.4 Sanofi Pasteur SA Business Overview
10.8.5 Sanofi Pasteur SA Recent Developments
10.9 Virbac
10.9.1 Virbac Basic Information
10.9.2 Virbac Gene Engineered Subunit Vaccine Product Overview
10.9.3 Virbac Gene Engineered Subunit Vaccine Product Market Performance
10.9.4 Virbac Business Overview
10.9.5 Virbac Recent Developments
10.10 Pfizer Inc.
10.10.1 Pfizer Inc. Basic Information
10.10.2 Pfizer Inc. Gene Engineered Subunit Vaccine Product Overview
10.10.3 Pfizer Inc. Gene Engineered Subunit Vaccine Product Market Performance
10.10.4 Pfizer Inc. Business Overview
10.10.5 Pfizer Inc. Recent Developments
10.11 Walvax Biotechnology
10.11.1 Walvax Biotechnology Basic Information
10.11.2 Walvax Biotechnology Gene Engineered Subunit Vaccine Product Overview
10.11.3 Walvax Biotechnology Gene Engineered Subunit Vaccine Product Market Performance
10.11.4 Walvax Biotechnology Business Overview
10.11.5 Walvax Biotechnology Recent Developments
10.12 Kontec
10.12.1 Kontec Basic Information
10.12.2 Kontec Gene Engineered Subunit Vaccine Product Overview
10.12.3 Kontec Gene Engineered Subunit Vaccine Product Market Performance
10.12.4 Kontec Business Overview
10.12.5 Kontec Recent Developments
10.13 Novavax
10.13.1 Novavax Basic Information
10.13.2 Novavax Gene Engineered Subunit Vaccine Product Overview
10.13.3 Novavax Gene Engineered Subunit Vaccine Product Market Performance
10.13.4 Novavax Business Overview
10.13.5 Novavax Recent Developments
10.14 Sanofi Pasteur
10.14.1 Sanofi Pasteur Basic Information
10.14.2 Sanofi Pasteur Gene Engineered Subunit Vaccine Product Overview
10.14.3 Sanofi Pasteur Gene Engineered Subunit Vaccine Product Market Performance
10.14.4 Sanofi Pasteur Business Overview
10.14.5 Sanofi Pasteur Recent Developments
10.15 Bharat Biotech
10.15.1 Bharat Biotech Basic Information
10.15.2 Bharat Biotech Gene Engineered Subunit Vaccine Product Overview
10.15.3 Bharat Biotech Gene Engineered Subunit Vaccine Product Market Performance
10.15.4 Bharat Biotech Business Overview
10.15.5 Bharat Biotech Recent Developments
10.16 GlaxoSmithKline
10.16.1 GlaxoSmithKline Basic Information
10.16.2 GlaxoSmithKline Gene Engineered Subunit Vaccine Product Overview
10.16.3 GlaxoSmithKline Gene Engineered Subunit Vaccine Product Market Performance
10.16.4 GlaxoSmithKline Business Overview
10.16.5 GlaxoSmithKline Recent Developments
10.17 Pfizer
10.17.1 Pfizer Basic Information
10.17.2 Pfizer Gene Engineered Subunit Vaccine Product Overview
10.17.3 Pfizer Gene Engineered Subunit Vaccine Product Market Performance
10.17.4 Pfizer Business Overview
10.17.5 Pfizer Recent Developments
10.18 Moderna
10.18.1 Moderna Basic Information
10.18.2 Moderna Gene Engineered Subunit Vaccine Product Overview
10.18.3 Moderna Gene Engineered Subunit Vaccine Product Market Performance
10.18.4 Moderna Business Overview
10.18.5 Moderna Recent Developments
11 GENE ENGINEERED SUBUNIT VACCINE MARKET FORECAST BY REGION
11.1 Global Gene Engineered Subunit Vaccine Market Size Forecast
11.2 Global Gene Engineered Subunit Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gene Engineered Subunit Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Gene Engineered Subunit Vaccine Market Size Forecast by Region
11.2.4 South America Gene Engineered Subunit Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gene Engineered Subunit Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Gene Engineered Subunit Vaccine Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Gene Engineered Subunit Vaccine by Type (2026-2033)
12.1.2 Global Gene Engineered Subunit Vaccine Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Gene Engineered Subunit Vaccine by Type (2026-2033)
12.2 Global Gene Engineered Subunit Vaccine Market Forecast by Application (2026-2033)
12.2.1 Global Gene Engineered Subunit Vaccine Sales (K Units) Forecast by Application
12.2.2 Global Gene Engineered Subunit Vaccine Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Gene Engineered Subunit Vaccine
1.2 Key Market Segments
1.2.1 Gene Engineered Subunit Vaccine Segment by Type
1.2.2 Gene Engineered Subunit Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENE ENGINEERED SUBUNIT VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gene Engineered Subunit Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Gene Engineered Subunit Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENE ENGINEERED SUBUNIT VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Gene Engineered Subunit Vaccine Product Life Cycle
3.3 Global Gene Engineered Subunit Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Gene Engineered Subunit Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Gene Engineered Subunit Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gene Engineered Subunit Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Gene Engineered Subunit Vaccine Market Competitive Situation and Trends
3.8.1 Gene Engineered Subunit Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gene Engineered Subunit Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GENE ENGINEERED SUBUNIT VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Gene Engineered Subunit Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENE ENGINEERED SUBUNIT VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gene Engineered Subunit Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Gene Engineered Subunit Vaccine Market
5.7 ESG Ratings of Leading Companies
6 GENE ENGINEERED SUBUNIT VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene Engineered Subunit Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Gene Engineered Subunit Vaccine Market Size Market Share by Type (2020-2025)
6.4 Global Gene Engineered Subunit Vaccine Price by Type (2020-2025)
7 GENE ENGINEERED SUBUNIT VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene Engineered Subunit Vaccine Market Sales by Application (2020-2025)
7.3 Global Gene Engineered Subunit Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Gene Engineered Subunit Vaccine Sales Growth Rate by Application (2020-2025)
8 GENE ENGINEERED SUBUNIT VACCINE MARKET SALES BY REGION
8.1 Global Gene Engineered Subunit Vaccine Sales by Region
8.1.1 Global Gene Engineered Subunit Vaccine Sales by Region
8.1.2 Global Gene Engineered Subunit Vaccine Sales Market Share by Region
8.2 Global Gene Engineered Subunit Vaccine Market Size by Region
8.2.1 Global Gene Engineered Subunit Vaccine Market Size by Region
8.2.2 Global Gene Engineered Subunit Vaccine Market Size Market Share by Region
8.3 North America
8.3.1 North America Gene Engineered Subunit Vaccine Sales by Country
8.3.2 North America Gene Engineered Subunit Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gene Engineered Subunit Vaccine Sales by Country
8.4.2 Europe Gene Engineered Subunit Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gene Engineered Subunit Vaccine Sales by Region
8.5.2 Asia Pacific Gene Engineered Subunit Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Gene Engineered Subunit Vaccine Sales by Country
8.6.2 South America Gene Engineered Subunit Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Gene Engineered Subunit Vaccine Sales by Region
8.7.2 Middle East and Africa Gene Engineered Subunit Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GENE ENGINEERED SUBUNIT VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Gene Engineered Subunit Vaccine by Region(2020-2025)
9.2 Global Gene Engineered Subunit Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Gene Engineered Subunit Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gene Engineered Subunit Vaccine Production
9.4.1 North America Gene Engineered Subunit Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Gene Engineered Subunit Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gene Engineered Subunit Vaccine Production
9.5.1 Europe Gene Engineered Subunit Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Gene Engineered Subunit Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gene Engineered Subunit Vaccine Production (2020-2025)
9.6.1 Japan Gene Engineered Subunit Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Gene Engineered Subunit Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gene Engineered Subunit Vaccine Production (2020-2025)
9.7.1 China Gene Engineered Subunit Vaccine Production Growth Rate (2020-2025)
9.7.2 China Gene Engineered Subunit Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Merck
10.1.1 Merck Basic Information
10.1.2 Merck Gene Engineered Subunit Vaccine Product Overview
10.1.3 Merck Gene Engineered Subunit Vaccine Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck SWOT Analysis
10.1.6 Merck Recent Developments
10.2 GSK
10.2.1 GSK Basic Information
10.2.2 GSK Gene Engineered Subunit Vaccine Product Overview
10.2.3 GSK Gene Engineered Subunit Vaccine Product Market Performance
10.2.4 GSK Business Overview
10.2.5 GSK SWOT Analysis
10.2.6 GSK Recent Developments
10.3 Tiantan
10.3.1 Tiantan Basic Information
10.3.2 Tiantan Gene Engineered Subunit Vaccine Product Overview
10.3.3 Tiantan Gene Engineered Subunit Vaccine Product Market Performance
10.3.4 Tiantan Business Overview
10.3.5 Tiantan SWOT Analysis
10.3.6 Tiantan Recent Developments
10.4 Pulike
10.4.1 Pulike Basic Information
10.4.2 Pulike Gene Engineered Subunit Vaccine Product Overview
10.4.3 Pulike Gene Engineered Subunit Vaccine Product Market Performance
10.4.4 Pulike Business Overview
10.4.5 Pulike Recent Developments
10.5 Greffex
10.5.1 Greffex Basic Information
10.5.2 Greffex Gene Engineered Subunit Vaccine Product Overview
10.5.3 Greffex Gene Engineered Subunit Vaccine Product Market Performance
10.5.4 Greffex Business Overview
10.5.5 Greffex Recent Developments
10.6 CureVac
10.6.1 CureVac Basic Information
10.6.2 CureVac Gene Engineered Subunit Vaccine Product Overview
10.6.3 CureVac Gene Engineered Subunit Vaccine Product Market Performance
10.6.4 CureVac Business Overview
10.6.5 CureVac Recent Developments
10.7 Yebio
10.7.1 Yebio Basic Information
10.7.2 Yebio Gene Engineered Subunit Vaccine Product Overview
10.7.3 Yebio Gene Engineered Subunit Vaccine Product Market Performance
10.7.4 Yebio Business Overview
10.7.5 Yebio Recent Developments
10.8 Sanofi Pasteur SA
10.8.1 Sanofi Pasteur SA Basic Information
10.8.2 Sanofi Pasteur SA Gene Engineered Subunit Vaccine Product Overview
10.8.3 Sanofi Pasteur SA Gene Engineered Subunit Vaccine Product Market Performance
10.8.4 Sanofi Pasteur SA Business Overview
10.8.5 Sanofi Pasteur SA Recent Developments
10.9 Virbac
10.9.1 Virbac Basic Information
10.9.2 Virbac Gene Engineered Subunit Vaccine Product Overview
10.9.3 Virbac Gene Engineered Subunit Vaccine Product Market Performance
10.9.4 Virbac Business Overview
10.9.5 Virbac Recent Developments
10.10 Pfizer Inc.
10.10.1 Pfizer Inc. Basic Information
10.10.2 Pfizer Inc. Gene Engineered Subunit Vaccine Product Overview
10.10.3 Pfizer Inc. Gene Engineered Subunit Vaccine Product Market Performance
10.10.4 Pfizer Inc. Business Overview
10.10.5 Pfizer Inc. Recent Developments
10.11 Walvax Biotechnology
10.11.1 Walvax Biotechnology Basic Information
10.11.2 Walvax Biotechnology Gene Engineered Subunit Vaccine Product Overview
10.11.3 Walvax Biotechnology Gene Engineered Subunit Vaccine Product Market Performance
10.11.4 Walvax Biotechnology Business Overview
10.11.5 Walvax Biotechnology Recent Developments
10.12 Kontec
10.12.1 Kontec Basic Information
10.12.2 Kontec Gene Engineered Subunit Vaccine Product Overview
10.12.3 Kontec Gene Engineered Subunit Vaccine Product Market Performance
10.12.4 Kontec Business Overview
10.12.5 Kontec Recent Developments
10.13 Novavax
10.13.1 Novavax Basic Information
10.13.2 Novavax Gene Engineered Subunit Vaccine Product Overview
10.13.3 Novavax Gene Engineered Subunit Vaccine Product Market Performance
10.13.4 Novavax Business Overview
10.13.5 Novavax Recent Developments
10.14 Sanofi Pasteur
10.14.1 Sanofi Pasteur Basic Information
10.14.2 Sanofi Pasteur Gene Engineered Subunit Vaccine Product Overview
10.14.3 Sanofi Pasteur Gene Engineered Subunit Vaccine Product Market Performance
10.14.4 Sanofi Pasteur Business Overview
10.14.5 Sanofi Pasteur Recent Developments
10.15 Bharat Biotech
10.15.1 Bharat Biotech Basic Information
10.15.2 Bharat Biotech Gene Engineered Subunit Vaccine Product Overview
10.15.3 Bharat Biotech Gene Engineered Subunit Vaccine Product Market Performance
10.15.4 Bharat Biotech Business Overview
10.15.5 Bharat Biotech Recent Developments
10.16 GlaxoSmithKline
10.16.1 GlaxoSmithKline Basic Information
10.16.2 GlaxoSmithKline Gene Engineered Subunit Vaccine Product Overview
10.16.3 GlaxoSmithKline Gene Engineered Subunit Vaccine Product Market Performance
10.16.4 GlaxoSmithKline Business Overview
10.16.5 GlaxoSmithKline Recent Developments
10.17 Pfizer
10.17.1 Pfizer Basic Information
10.17.2 Pfizer Gene Engineered Subunit Vaccine Product Overview
10.17.3 Pfizer Gene Engineered Subunit Vaccine Product Market Performance
10.17.4 Pfizer Business Overview
10.17.5 Pfizer Recent Developments
10.18 Moderna
10.18.1 Moderna Basic Information
10.18.2 Moderna Gene Engineered Subunit Vaccine Product Overview
10.18.3 Moderna Gene Engineered Subunit Vaccine Product Market Performance
10.18.4 Moderna Business Overview
10.18.5 Moderna Recent Developments
11 GENE ENGINEERED SUBUNIT VACCINE MARKET FORECAST BY REGION
11.1 Global Gene Engineered Subunit Vaccine Market Size Forecast
11.2 Global Gene Engineered Subunit Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gene Engineered Subunit Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Gene Engineered Subunit Vaccine Market Size Forecast by Region
11.2.4 South America Gene Engineered Subunit Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gene Engineered Subunit Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Gene Engineered Subunit Vaccine Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Gene Engineered Subunit Vaccine by Type (2026-2033)
12.1.2 Global Gene Engineered Subunit Vaccine Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Gene Engineered Subunit Vaccine by Type (2026-2033)
12.2 Global Gene Engineered Subunit Vaccine Market Forecast by Application (2026-2033)
12.2.1 Global Gene Engineered Subunit Vaccine Sales (K Units) Forecast by Application
12.2.2 Global Gene Engineered Subunit Vaccine Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gene Engineered Subunit Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Gene Engineered Subunit Vaccine Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Gene Engineered Subunit Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Gene Engineered Subunit Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Gene Engineered Subunit Vaccine Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Engineered Subunit Vaccine as of 2024)
Table 10. Global Market Gene Engineered Subunit Vaccine Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Gene Engineered Subunit Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Gene Engineered Subunit Vaccine Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Gene Engineered Subunit Vaccine Sales by Type (K Units)
Table 26. Global Gene Engineered Subunit Vaccine Market Size by Type (M USD)
Table 27. Global Gene Engineered Subunit Vaccine Sales (K Units) by Type (2020-2025)
Table 28. Global Gene Engineered Subunit Vaccine Sales Market Share by Type (2020-2025)
Table 29. Global Gene Engineered Subunit Vaccine Market Size (M USD) by Type (2020-2025)
Table 30. Global Gene Engineered Subunit Vaccine Market Size Share by Type (2020-2025)
Table 31. Global Gene Engineered Subunit Vaccine Price (USD/Unit) by Type (2020-2025)
Table 32. Global Gene Engineered Subunit Vaccine Sales (K Units) by Application
Table 33. Global Gene Engineered Subunit Vaccine Market Size by Application
Table 34. Global Gene Engineered Subunit Vaccine Sales by Application (2020-2025) & (K Units)
Table 35. Global Gene Engineered Subunit Vaccine Sales Market Share by Application (2020-2025)
Table 36. Global Gene Engineered Subunit Vaccine Market Size by Application (2020-2025) & (M USD)
Table 37. Global Gene Engineered Subunit Vaccine Market Share by Application (2020-2025)
Table 38. Global Gene Engineered Subunit Vaccine Sales Growth Rate by Application (2020-2025)
Table 39. Global Gene Engineered Subunit Vaccine Sales by Region (2020-2025) & (K Units)
Table 40. Global Gene Engineered Subunit Vaccine Sales Market Share by Region (2020-2025)
Table 41. Global Gene Engineered Subunit Vaccine Market Size by Region (2020-2025) & (M USD)
Table 42. Global Gene Engineered Subunit Vaccine Market Size Market Share by Region (2020-2025)
Table 43. North America Gene Engineered Subunit Vaccine Sales by Country (2020-2025) & (K Units)
Table 44. North America Gene Engineered Subunit Vaccine Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Gene Engineered Subunit Vaccine Sales by Country (2020-2025) & (K Units)
Table 46. Europe Gene Engineered Subunit Vaccine Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Gene Engineered Subunit Vaccine Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Gene Engineered Subunit Vaccine Market Size by Region (2020-2025) & (M USD)
Table 49. South America Gene Engineered Subunit Vaccine Sales by Country (2020-2025) & (K Units)
Table 50. South America Gene Engineered Subunit Vaccine Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Gene Engineered Subunit Vaccine Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Gene Engineered Subunit Vaccine Market Size by Region (2020-2025) & (M USD)
Table 53. Global Gene Engineered Subunit Vaccine Production (K Units) by Region(2020-2025)
Table 54. Global Gene Engineered Subunit Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Gene Engineered Subunit Vaccine Revenue Market Share by Region (2020-2025)
Table 56. Global Gene Engineered Subunit Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Gene Engineered Subunit Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Gene Engineered Subunit Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Gene Engineered Subunit Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Gene Engineered Subunit Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Merck Basic Information
Table 62. Merck Gene Engineered Subunit Vaccine Product Overview
Table 63. Merck Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Merck Business Overview
Table 65. Merck SWOT Analysis
Table 66. Merck Recent Developments
Table 67. GSK Basic Information
Table 68. GSK Gene Engineered Subunit Vaccine Product Overview
Table 69. GSK Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. GSK Business Overview
Table 71. GSK SWOT Analysis
Table 72. GSK Recent Developments
Table 73. Tiantan Basic Information
Table 74. Tiantan Gene Engineered Subunit Vaccine Product Overview
Table 75. Tiantan Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Tiantan Business Overview
Table 77. Tiantan SWOT Analysis
Table 78. Tiantan Recent Developments
Table 79. Pulike Basic Information
Table 80. Pulike Gene Engineered Subunit Vaccine Product Overview
Table 81. Pulike Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Pulike Business Overview
Table 83. Pulike Recent Developments
Table 84. Greffex Basic Information
Table 85. Greffex Gene Engineered Subunit Vaccine Product Overview
Table 86. Greffex Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Greffex Business Overview
Table 88. Greffex Recent Developments
Table 89. CureVac Basic Information
Table 90. CureVac Gene Engineered Subunit Vaccine Product Overview
Table 91. CureVac Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. CureVac Business Overview
Table 93. CureVac Recent Developments
Table 94. Yebio Basic Information
Table 95. Yebio Gene Engineered Subunit Vaccine Product Overview
Table 96. Yebio Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Yebio Business Overview
Table 98. Yebio Recent Developments
Table 99. Sanofi Pasteur SA Basic Information
Table 100. Sanofi Pasteur SA Gene Engineered Subunit Vaccine Product Overview
Table 101. Sanofi Pasteur SA Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Sanofi Pasteur SA Business Overview
Table 103. Sanofi Pasteur SA Recent Developments
Table 104. Virbac Basic Information
Table 105. Virbac Gene Engineered Subunit Vaccine Product Overview
Table 106. Virbac Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Virbac Business Overview
Table 108. Virbac Recent Developments
Table 109. Pfizer Inc. Basic Information
Table 110. Pfizer Inc. Gene Engineered Subunit Vaccine Product Overview
Table 111. Pfizer Inc. Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Pfizer Inc. Business Overview
Table 113. Pfizer Inc. Recent Developments
Table 114. Walvax Biotechnology Basic Information
Table 115. Walvax Biotechnology Gene Engineered Subunit Vaccine Product Overview
Table 116. Walvax Biotechnology Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Walvax Biotechnology Business Overview
Table 118. Walvax Biotechnology Recent Developments
Table 119. Kontec Basic Information
Table 120. Kontec Gene Engineered Subunit Vaccine Product Overview
Table 121. Kontec Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Kontec Business Overview
Table 123. Kontec Recent Developments
Table 124. Novavax Basic Information
Table 125. Novavax Gene Engineered Subunit Vaccine Product Overview
Table 126. Novavax Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Novavax Business Overview
Table 128. Novavax Recent Developments
Table 129. Sanofi Pasteur Basic Information
Table 130. Sanofi Pasteur Gene Engineered Subunit Vaccine Product Overview
Table 131. Sanofi Pasteur Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Sanofi Pasteur Business Overview
Table 133. Sanofi Pasteur Recent Developments
Table 134. Bharat Biotech Basic Information
Table 135. Bharat Biotech Gene Engineered Subunit Vaccine Product Overview
Table 136. Bharat Biotech Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Bharat Biotech Business Overview
Table 138. Bharat Biotech Recent Developments
Table 139. GlaxoSmithKline Basic Information
Table 140. GlaxoSmithKline Gene Engineered Subunit Vaccine Product Overview
Table 141. GlaxoSmithKline Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. GlaxoSmithKline Business Overview
Table 143. GlaxoSmithKline Recent Developments
Table 144. Pfizer Basic Information
Table 145. Pfizer Gene Engineered Subunit Vaccine Product Overview
Table 146. Pfizer Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Pfizer Business Overview
Table 148. Pfizer Recent Developments
Table 149. Moderna Basic Information
Table 150. Moderna Gene Engineered Subunit Vaccine Product Overview
Table 151. Moderna Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Moderna Business Overview
Table 153. Moderna Recent Developments
Table 154. Global Gene Engineered Subunit Vaccine Sales Forecast by Region (2026-2033) & (K Units)
Table 155. Global Gene Engineered Subunit Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 156. North America Gene Engineered Subunit Vaccine Sales Forecast by Country (2026-2033) & (K Units)
Table 157. North America Gene Engineered Subunit Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 158. Europe Gene Engineered Subunit Vaccine Sales Forecast by Country (2026-2033) & (K Units)
Table 159. Europe Gene Engineered Subunit Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 160. Asia Pacific Gene Engineered Subunit Vaccine Sales Forecast by Region (2026-2033) & (K Units)
Table 161. Asia Pacific Gene Engineered Subunit Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 162. South America Gene Engineered Subunit Vaccine Sales Forecast by Country (2026-2033) & (K Units)
Table 163. South America Gene Engineered Subunit Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 164. Middle East and Africa Gene Engineered Subunit Vaccine Sales Forecast by Country (2026-2033) & (Units)
Table 165. Middle East and Africa Gene Engineered Subunit Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 166. Global Gene Engineered Subunit Vaccine Sales Forecast by Type (2026-2033) & (K Units)
Table 167. Global Gene Engineered Subunit Vaccine Market Size Forecast by Type (2026-2033) & (M USD)
Table 168. Global Gene Engineered Subunit Vaccine Price Forecast by Type (2026-2033) & (USD/Unit)
Table 169. Global Gene Engineered Subunit Vaccine Sales (K Units) Forecast by Application (2026-2033)
Table 170. Global Gene Engineered Subunit Vaccine Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gene Engineered Subunit Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Gene Engineered Subunit Vaccine Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Gene Engineered Subunit Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Gene Engineered Subunit Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Gene Engineered Subunit Vaccine Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Engineered Subunit Vaccine as of 2024)
Table 10. Global Market Gene Engineered Subunit Vaccine Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Gene Engineered Subunit Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Gene Engineered Subunit Vaccine Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Gene Engineered Subunit Vaccine Sales by Type (K Units)
Table 26. Global Gene Engineered Subunit Vaccine Market Size by Type (M USD)
Table 27. Global Gene Engineered Subunit Vaccine Sales (K Units) by Type (2020-2025)
Table 28. Global Gene Engineered Subunit Vaccine Sales Market Share by Type (2020-2025)
Table 29. Global Gene Engineered Subunit Vaccine Market Size (M USD) by Type (2020-2025)
Table 30. Global Gene Engineered Subunit Vaccine Market Size Share by Type (2020-2025)
Table 31. Global Gene Engineered Subunit Vaccine Price (USD/Unit) by Type (2020-2025)
Table 32. Global Gene Engineered Subunit Vaccine Sales (K Units) by Application
Table 33. Global Gene Engineered Subunit Vaccine Market Size by Application
Table 34. Global Gene Engineered Subunit Vaccine Sales by Application (2020-2025) & (K Units)
Table 35. Global Gene Engineered Subunit Vaccine Sales Market Share by Application (2020-2025)
Table 36. Global Gene Engineered Subunit Vaccine Market Size by Application (2020-2025) & (M USD)
Table 37. Global Gene Engineered Subunit Vaccine Market Share by Application (2020-2025)
Table 38. Global Gene Engineered Subunit Vaccine Sales Growth Rate by Application (2020-2025)
Table 39. Global Gene Engineered Subunit Vaccine Sales by Region (2020-2025) & (K Units)
Table 40. Global Gene Engineered Subunit Vaccine Sales Market Share by Region (2020-2025)
Table 41. Global Gene Engineered Subunit Vaccine Market Size by Region (2020-2025) & (M USD)
Table 42. Global Gene Engineered Subunit Vaccine Market Size Market Share by Region (2020-2025)
Table 43. North America Gene Engineered Subunit Vaccine Sales by Country (2020-2025) & (K Units)
Table 44. North America Gene Engineered Subunit Vaccine Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Gene Engineered Subunit Vaccine Sales by Country (2020-2025) & (K Units)
Table 46. Europe Gene Engineered Subunit Vaccine Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Gene Engineered Subunit Vaccine Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Gene Engineered Subunit Vaccine Market Size by Region (2020-2025) & (M USD)
Table 49. South America Gene Engineered Subunit Vaccine Sales by Country (2020-2025) & (K Units)
Table 50. South America Gene Engineered Subunit Vaccine Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Gene Engineered Subunit Vaccine Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Gene Engineered Subunit Vaccine Market Size by Region (2020-2025) & (M USD)
Table 53. Global Gene Engineered Subunit Vaccine Production (K Units) by Region(2020-2025)
Table 54. Global Gene Engineered Subunit Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Gene Engineered Subunit Vaccine Revenue Market Share by Region (2020-2025)
Table 56. Global Gene Engineered Subunit Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Gene Engineered Subunit Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Gene Engineered Subunit Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Gene Engineered Subunit Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Gene Engineered Subunit Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Merck Basic Information
Table 62. Merck Gene Engineered Subunit Vaccine Product Overview
Table 63. Merck Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Merck Business Overview
Table 65. Merck SWOT Analysis
Table 66. Merck Recent Developments
Table 67. GSK Basic Information
Table 68. GSK Gene Engineered Subunit Vaccine Product Overview
Table 69. GSK Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. GSK Business Overview
Table 71. GSK SWOT Analysis
Table 72. GSK Recent Developments
Table 73. Tiantan Basic Information
Table 74. Tiantan Gene Engineered Subunit Vaccine Product Overview
Table 75. Tiantan Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Tiantan Business Overview
Table 77. Tiantan SWOT Analysis
Table 78. Tiantan Recent Developments
Table 79. Pulike Basic Information
Table 80. Pulike Gene Engineered Subunit Vaccine Product Overview
Table 81. Pulike Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Pulike Business Overview
Table 83. Pulike Recent Developments
Table 84. Greffex Basic Information
Table 85. Greffex Gene Engineered Subunit Vaccine Product Overview
Table 86. Greffex Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Greffex Business Overview
Table 88. Greffex Recent Developments
Table 89. CureVac Basic Information
Table 90. CureVac Gene Engineered Subunit Vaccine Product Overview
Table 91. CureVac Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. CureVac Business Overview
Table 93. CureVac Recent Developments
Table 94. Yebio Basic Information
Table 95. Yebio Gene Engineered Subunit Vaccine Product Overview
Table 96. Yebio Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Yebio Business Overview
Table 98. Yebio Recent Developments
Table 99. Sanofi Pasteur SA Basic Information
Table 100. Sanofi Pasteur SA Gene Engineered Subunit Vaccine Product Overview
Table 101. Sanofi Pasteur SA Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Sanofi Pasteur SA Business Overview
Table 103. Sanofi Pasteur SA Recent Developments
Table 104. Virbac Basic Information
Table 105. Virbac Gene Engineered Subunit Vaccine Product Overview
Table 106. Virbac Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Virbac Business Overview
Table 108. Virbac Recent Developments
Table 109. Pfizer Inc. Basic Information
Table 110. Pfizer Inc. Gene Engineered Subunit Vaccine Product Overview
Table 111. Pfizer Inc. Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Pfizer Inc. Business Overview
Table 113. Pfizer Inc. Recent Developments
Table 114. Walvax Biotechnology Basic Information
Table 115. Walvax Biotechnology Gene Engineered Subunit Vaccine Product Overview
Table 116. Walvax Biotechnology Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Walvax Biotechnology Business Overview
Table 118. Walvax Biotechnology Recent Developments
Table 119. Kontec Basic Information
Table 120. Kontec Gene Engineered Subunit Vaccine Product Overview
Table 121. Kontec Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Kontec Business Overview
Table 123. Kontec Recent Developments
Table 124. Novavax Basic Information
Table 125. Novavax Gene Engineered Subunit Vaccine Product Overview
Table 126. Novavax Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Novavax Business Overview
Table 128. Novavax Recent Developments
Table 129. Sanofi Pasteur Basic Information
Table 130. Sanofi Pasteur Gene Engineered Subunit Vaccine Product Overview
Table 131. Sanofi Pasteur Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Sanofi Pasteur Business Overview
Table 133. Sanofi Pasteur Recent Developments
Table 134. Bharat Biotech Basic Information
Table 135. Bharat Biotech Gene Engineered Subunit Vaccine Product Overview
Table 136. Bharat Biotech Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Bharat Biotech Business Overview
Table 138. Bharat Biotech Recent Developments
Table 139. GlaxoSmithKline Basic Information
Table 140. GlaxoSmithKline Gene Engineered Subunit Vaccine Product Overview
Table 141. GlaxoSmithKline Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. GlaxoSmithKline Business Overview
Table 143. GlaxoSmithKline Recent Developments
Table 144. Pfizer Basic Information
Table 145. Pfizer Gene Engineered Subunit Vaccine Product Overview
Table 146. Pfizer Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Pfizer Business Overview
Table 148. Pfizer Recent Developments
Table 149. Moderna Basic Information
Table 150. Moderna Gene Engineered Subunit Vaccine Product Overview
Table 151. Moderna Gene Engineered Subunit Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Moderna Business Overview
Table 153. Moderna Recent Developments
Table 154. Global Gene Engineered Subunit Vaccine Sales Forecast by Region (2026-2033) & (K Units)
Table 155. Global Gene Engineered Subunit Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 156. North America Gene Engineered Subunit Vaccine Sales Forecast by Country (2026-2033) & (K Units)
Table 157. North America Gene Engineered Subunit Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 158. Europe Gene Engineered Subunit Vaccine Sales Forecast by Country (2026-2033) & (K Units)
Table 159. Europe Gene Engineered Subunit Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 160. Asia Pacific Gene Engineered Subunit Vaccine Sales Forecast by Region (2026-2033) & (K Units)
Table 161. Asia Pacific Gene Engineered Subunit Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 162. South America Gene Engineered Subunit Vaccine Sales Forecast by Country (2026-2033) & (K Units)
Table 163. South America Gene Engineered Subunit Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 164. Middle East and Africa Gene Engineered Subunit Vaccine Sales Forecast by Country (2026-2033) & (Units)
Table 165. Middle East and Africa Gene Engineered Subunit Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 166. Global Gene Engineered Subunit Vaccine Sales Forecast by Type (2026-2033) & (K Units)
Table 167. Global Gene Engineered Subunit Vaccine Market Size Forecast by Type (2026-2033) & (M USD)
Table 168. Global Gene Engineered Subunit Vaccine Price Forecast by Type (2026-2033) & (USD/Unit)
Table 169. Global Gene Engineered Subunit Vaccine Sales (K Units) Forecast by Application (2026-2033)
Table 170. Global Gene Engineered Subunit Vaccine Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Gene Engineered Subunit Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gene Engineered Subunit Vaccine Market Size (M USD), 2024-2033
Figure 5. Global Gene Engineered Subunit Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global Gene Engineered Subunit Vaccine Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gene Engineered Subunit Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gene Engineered Subunit Vaccine Product Life Cycle
Figure 13. Gene Engineered Subunit Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global Gene Engineered Subunit Vaccine Revenue Share by Manufacturers in 2024
Figure 15. Gene Engineered Subunit Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Gene Engineered Subunit Vaccine Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gene Engineered Subunit Vaccine Revenue in 2024
Figure 18. Industry Chain Map of Gene Engineered Subunit Vaccine
Figure 19. Global Gene Engineered Subunit Vaccine Market PEST Analysis
Figure 20. Global Gene Engineered Subunit Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Gene Engineered Subunit Vaccine Market Share by Type
Figure 27. Sales Market Share of Gene Engineered Subunit Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Gene Engineered Subunit Vaccine by Type in 2024
Figure 29. Market Size Share of Gene Engineered Subunit Vaccine by Type (2020-2025)
Figure 30. Market Size Share of Gene Engineered Subunit Vaccine by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Gene Engineered Subunit Vaccine Market Share by Application
Figure 33. Global Gene Engineered Subunit Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Gene Engineered Subunit Vaccine Sales Market Share by Application in 2024
Figure 35. Global Gene Engineered Subunit Vaccine Market Share by Application (2020-2025)
Figure 36. Global Gene Engineered Subunit Vaccine Market Share by Application in 2024
Figure 37. Global Gene Engineered Subunit Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Gene Engineered Subunit Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Gene Engineered Subunit Vaccine Market Size Market Share by Region (2020-2025)
Figure 40. North America Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Gene Engineered Subunit Vaccine Sales Market Share by Country in 2024
Figure 43. North America Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Gene Engineered Subunit Vaccine Market Size Market Share by Country in 2024
Figure 45. U.S. Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Gene Engineered Subunit Vaccine Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Gene Engineered Subunit Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Gene Engineered Subunit Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Gene Engineered Subunit Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Gene Engineered Subunit Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Gene Engineered Subunit Vaccine Market Size Market Share by Country in 2024
Figure 55. Germany Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Gene Engineered Subunit Vaccine Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Gene Engineered Subunit Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Gene Engineered Subunit Vaccine Market Size Market Share by Region in 2024
Figure 68. China Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Gene Engineered Subunit Vaccine Sales and Growth Rate (K Units)
Figure 79. South America Gene Engineered Subunit Vaccine Sales Market Share by Country in 2024
Figure 80. South America Gene Engineered Subunit Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Gene Engineered Subunit Vaccine Market Size Market Share by Country in 2024
Figure 82. Brazil Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Gene Engineered Subunit Vaccine Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Gene Engineered Subunit Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Gene Engineered Subunit Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Gene Engineered Subunit Vaccine Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Gene Engineered Subunit Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Gene Engineered Subunit Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Gene Engineered Subunit Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Gene Engineered Subunit Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 106. China Gene Engineered Subunit Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Gene Engineered Subunit Vaccine Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Gene Engineered Subunit Vaccine Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Gene Engineered Subunit Vaccine Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Gene Engineered Subunit Vaccine Market Share Forecast by Type (2026-2033)
Figure 111. Global Gene Engineered Subunit Vaccine Sales Forecast by Application (2026-2033)
Figure 112. Global Gene Engineered Subunit Vaccine Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Gene Engineered Subunit Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gene Engineered Subunit Vaccine Market Size (M USD), 2024-2033
Figure 5. Global Gene Engineered Subunit Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global Gene Engineered Subunit Vaccine Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gene Engineered Subunit Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gene Engineered Subunit Vaccine Product Life Cycle
Figure 13. Gene Engineered Subunit Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global Gene Engineered Subunit Vaccine Revenue Share by Manufacturers in 2024
Figure 15. Gene Engineered Subunit Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Gene Engineered Subunit Vaccine Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gene Engineered Subunit Vaccine Revenue in 2024
Figure 18. Industry Chain Map of Gene Engineered Subunit Vaccine
Figure 19. Global Gene Engineered Subunit Vaccine Market PEST Analysis
Figure 20. Global Gene Engineered Subunit Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Gene Engineered Subunit Vaccine Market Share by Type
Figure 27. Sales Market Share of Gene Engineered Subunit Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Gene Engineered Subunit Vaccine by Type in 2024
Figure 29. Market Size Share of Gene Engineered Subunit Vaccine by Type (2020-2025)
Figure 30. Market Size Share of Gene Engineered Subunit Vaccine by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Gene Engineered Subunit Vaccine Market Share by Application
Figure 33. Global Gene Engineered Subunit Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Gene Engineered Subunit Vaccine Sales Market Share by Application in 2024
Figure 35. Global Gene Engineered Subunit Vaccine Market Share by Application (2020-2025)
Figure 36. Global Gene Engineered Subunit Vaccine Market Share by Application in 2024
Figure 37. Global Gene Engineered Subunit Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Gene Engineered Subunit Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Gene Engineered Subunit Vaccine Market Size Market Share by Region (2020-2025)
Figure 40. North America Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Gene Engineered Subunit Vaccine Sales Market Share by Country in 2024
Figure 43. North America Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Gene Engineered Subunit Vaccine Market Size Market Share by Country in 2024
Figure 45. U.S. Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Gene Engineered Subunit Vaccine Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Gene Engineered Subunit Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Gene Engineered Subunit Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Gene Engineered Subunit Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Gene Engineered Subunit Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Gene Engineered Subunit Vaccine Market Size Market Share by Country in 2024
Figure 55. Germany Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Gene Engineered Subunit Vaccine Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Gene Engineered Subunit Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Gene Engineered Subunit Vaccine Market Size Market Share by Region in 2024
Figure 68. China Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Gene Engineered Subunit Vaccine Sales and Growth Rate (K Units)
Figure 79. South America Gene Engineered Subunit Vaccine Sales Market Share by Country in 2024
Figure 80. South America Gene Engineered Subunit Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Gene Engineered Subunit Vaccine Market Size Market Share by Country in 2024
Figure 82. Brazil Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Gene Engineered Subunit Vaccine Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Gene Engineered Subunit Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Gene Engineered Subunit Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Gene Engineered Subunit Vaccine Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Gene Engineered Subunit Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Gene Engineered Subunit Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Gene Engineered Subunit Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Gene Engineered Subunit Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Gene Engineered Subunit Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Gene Engineered Subunit Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 106. China Gene Engineered Subunit Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Gene Engineered Subunit Vaccine Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Gene Engineered Subunit Vaccine Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Gene Engineered Subunit Vaccine Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Gene Engineered Subunit Vaccine Market Share Forecast by Type (2026-2033)
Figure 111. Global Gene Engineered Subunit Vaccine Sales Forecast by Application (2026-2033)
Figure 112. Global Gene Engineered Subunit Vaccine Market Share Forecast by Application (2026-2033)
